Cardio Diagnostics Holdings, Inc. today announced the Company has partnered with 15 new provider organizations across the United States.
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its third quarter 2025 financial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback